At a glance
- Originator Eli Lilly and Company
- Class Antidepressants; Propylamines; Small molecules
- Mechanism of Action Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Major depressive disorder
Most Recent Events
- 07 Jun 2001 No-Development-Reported for Depression in USA (Unknown route)
- 03 Jan 1997 Preclinical development for Depression in USA (Unknown route)